Want to join the conversation?
$CA 1Q16 Q&A: Ken R. Talanian from JPMorgan questions about new releases of older products, where would you say you sort of turning over that older product portfolio. Mike answered, in APM we are in medium-to-early stages, in UIM we have a lot of work to do, and we are in medium turn stages with flagship security products.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?